NCT02581670

Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer

Prospective Non-randomized Phase II Study on Stereotactic Body Radiation Therapy for Medically Inoperable Lung and Liver Oligometastases From Breast Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 65 (actual)
• Sponsor: Istituto Clinico Humanitas · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Investigators designed a phase II study to evaluate safety and efficacy of lung and liver stereotactic radiation therapy (SRT) in oligometastatic breast cancer patients unsuitable for surgery, using VMAT RapidArc approach.

Detailed description

Investigators designed a prospective phase II study to evaluate safety and efficacy of lung and liver stereotactic radiation therapy (SRT) scheduled for oligometastatic breast cancer patients unsuitable for surgery with age major than 18 years old and with adequate performance status (ECOG), using VMAT RapidArc approach. The potential advantage of this technique is the ability to deliver a more selective irradiation to tumour's target while reducing doses to normal tissue, optimizing the therapeutic window.

Conditions

• Breast Cancer
• Metastasis to Liver
• Metastasis to Lung

Interventions

Type	Name	Description
RADIATION	stereotactic radiation therapy (SRT)	Lung and liver stereotactic radiation therapy (SRT) in oligometastatic breast cancer patients unsuitable for surgery, using VMAT RapidArc approach

Timeline

• Start date: 2015-11-04
• Primary completion: 2023-10-01
• Completion: 2023-10-01
• First posted: 2015-10-21
• Last updated: 2022-05-04

Locations

1 site across 1 country: Italy